Jubilant Pharmova has a diversified & unique business model with new growth drivers. 30% upside

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Oct 7, 2024 at 7:34 PM.

Tags:
Previous Thread Next Thread
Loading...
  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    678
    Likes Received:
    55
    Jubilant Pharmova has a diversified & unique business model with new growth drivers & multiple triggers. It has growth visibility & revenue potential of $350 Mn. Co is embarking on a new earnings cycle. PAT has potential to grow 4x. TP ₹1450 (30%)

    Download research report

    [​IMG]
     
    Vidhi Khanna, Oct 7, 2024 at 7:34 PM
    #1
Previous Thread Next Thread
Loading...
Loading...
Similar Threads
  1. Vidhi Khanna

    Jubilant Foodworks is a hot pick with 41% upside

    Vidhi Khanna, Oct 9, 2022, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    472
    Vidhi Khanna
    Oct 9, 2022
  2. vineet

    Jubilant life sciences

    vineet, Jul 12, 2016, in forum: Stock Picks Of Wizards
    Replies:
    6
    Views:
    2,232
    w4wealth
    Aug 19, 2016
  3. Vidhi Khanna

    Jubilant Foodworks Ltd: The rise of the Quick Bite!!! - BUY

    Vidhi Khanna, Dec 23, 2015, in forum: Latest Brokerage Stock Buy-Sell Reports
    Replies:
    0
    Views:
    1,763
    Vidhi Khanna
    Dec 23, 2015
  4. RAMA MURTHY SASTRY CHALLA

    Jubilant Life Sciences submits copy of press release

    RAMA MURTHY SASTRY CHALLA, Oct 20, 2015, in forum: Must-Read Interviews, Articles & News Items
    Replies:
    0
    Views:
    965
    RAMA MURTHY SASTRY CHALLA
    Oct 20, 2015
  5. Warrenbuff77

    Jubilant life sciences

    Warrenbuff77, Oct 8, 2015, in forum: Ask A Query About Your Stock Picks And Portfolio
    Replies:
    0
    Views:
    1,216
    Warrenbuff77
    Oct 8, 2015